Article Listing - Merck KGaA strengthens research cooperation with Israel; files for Erbitux indication extension

BIOGEN'S DAVID CUOCO

4 May 1992

Biogen has appointed David Cuoco as vice president and legal counsel for the company. Mr Cuoco was formerly senior vice...

APPOINTMENTS AT BAYER

4 May 1992

Mannfred Schneider has been named as president of Bayer AG of Germany, in succession to Hermann Strenger. Dr Schneid-er is...

DERMALIFE ACQUIRES IDIM

4 May 1992

The Italian company Dermalife, which specializes in skin care products, has announced that it has acquired total control of the...

PFIZER RESEARCH SPENDING IN 1992

4 May 1992

US pharmaceutical manufacturer Pfizer said that it intends to spend $866 million on research and development in the current year,...

STOCK MARKET COMMENTARY: EUROPE

4 May 1992

EUROPE: ended another holiday-shortened week in mixed form, with political and industrial uncertainty casting a shadow in Germany and putting...

STOCK MARKET COMMENTARY: NEW YORK

4 May 1992

NEW YORK: ended the re-porting week with a skid, albeit up on the previous week's close, as investors moved their...

1991 MARKED SIGNIFICANT YEAR FOR DEPRENYL

4 May 1992

With the announcement that Canada's Deprenyl Research Limited has received approval to market its monoamine oxidase type B inhibitor product...

DAINIPPON STARTS US ZONISAMIDE TRIALS

4 May 1992

Dainippon Pharmaceutical is shortly to start clinical development of its anti-epileptic zonisamide in the USA, according to Pharma Japan. The...

NEW INT VACCINES CENTER FOR ITALY

4 May 1992

A major international vaccines research and development and production center has been set up in Siena, Italy, with the support...

COMPANIES DO MORE LICENSING DEALS

4 May 1992

There has been an increase in out-licensing of late-stage development drugs or mature drug product lines from research-intensive established drug...

Showing 94311-94320 of 95579 articles

Go to beginningPreviousNextGo to end